Spectranetics to Present at Canaccord Adams' 28th Annual Global Growth Conference on August 13

Spectranetics Corporation (Nasdaq:SPNC) today announced that it will present at Canaccord Adams’ 28th Annual Global Growth Conference to be held in Boston from August 12-14 at the Intercontinental Boston Hotel. John G. Schulte, Spectranetics’ president and chief executive officer, is scheduled to speak on Wednesday, August 13, 2008 at 8:30 a.m. Eastern time (6:30 a.m. Mountain time) and will discuss the Company's strategic initiatives, product pipeline and market opportunities. Interested parties can access a live audio webcast and slide presentation at www.spectranetics.com. An archived presentation will be available on the Web site for 14 days. The Canaccord Adams Global Growth Conference is one of the oldest and largest programs showcasing both publicly traded and privately held growth companies. Many of the presenting public companies are covered by Canaccord Adams’ global team of equity analysts. To learn more about the conference, please contact Nadine Miller at 617.371.3842 or Nadine.Miller@CanaccordAdams.com. About Spectranetics Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company’s disposable catheters use high-energy "cool” ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information visit www.spectranetics.com.